Litcius/Paper detail

One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response

Marco Caminati, Veronica Batani, Lucia Guidolin, Giuliana Festi, Gianenrico Senna

2022European Journal of Internal Medicine17 citationsDOI

Topics & Concepts

Allergic bronchopulmonary aspergillosisMedicineBronchiectasisPrednisoloneAsthmaItraconazoleExhaled nitric oxideFluticasoneImmunoglobulin EImmunologyGastroenterologyDermatologyInternal medicineLungAntifungalSpirometryAntibodyAsthma and respiratory diseasesAntifungal resistance and susceptibilityRespiratory and Cough-Related Research
One-year mepolizumab for Allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response | Litcius